Redmile Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-419,568
| Closed | -$14.3M | – | 73 |
|
|
2023
Q3 | $14.3M | Sell |
419,568
-700,908
| -63% | -$23.9M | 0.68% | 35 |
|
|
2023
Q2 | $43.1M | Sell |
1,120,476
-205,356
| -15% | -$7.91M | 1.66% | 16 |
|
|
2023
Q1 | $47.5M | Sell |
1,325,832
-1,034,582
| -44% | -$37M | 2.06% | 17 |
|
|
2022
Q4 | $93.1M | Sell |
2,360,414
-10,200
| -0.4% | -$402K | 3.81% | 7 |
|
|
2022
Q3 | $85.6M | Buy |
2,370,614
+731,270
| +45% | +$26.4M | 3.32% | 6 |
|
|
2022
Q2 | $49.9M | Buy |
+1,639,344
| New | +$49.9M | 1.9% | 16 |
|